Evidence map›Paper›PMID 35218452›Full record

ArticleAIDS and behavior2022

Women's Perceptions of HIV- and Sexuality-Related Stigma in Relation to PrEP: Qualitative Findings from the Masibambane Study, Durban, South Africa.

S Bergam, A D Harrison, N Benghu, S Khumalo, N Tesfay, T Exner, L Miller, C Dolezal, J Hanass-Hancock, S Hoffman

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in AIDS and behavior, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04833127 (Developing a Gender-Enhanced Pre-Exposure Prophylaxis), which is not on this map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04833127 phase1completednot on this map

Developing a Gender-Enhanced Pre-Exposure Prophylaxis (PrEP) Information-Motivational Workshop for Young South African Women

TypeinterventionalSponsorNew York State Psychiatric InstituteRan2021 to 2022Enrolled100ConditionsHIV InfectionsArmsGender-Enhanced -- Masibambane, Individually accessed
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

S BergamDepartment of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI, USA. scarlettbergam@gmail.com.ORCID https://orcid.org/0000-0001-6550-8508
A D HarrisonDepartment of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI, USA.ORCID https://orcid.org/0000-0002-1673-8486
N BenghuGender and Health Research Unit, South African Medical Research Council, Durban, Kwa-Zulu Natal, South Africa.
S KhumaloGender and Health Research Unit, South African Medical Research Council, Durban, Kwa-Zulu Natal, South Africa.
N TesfayGender and Health Research Unit, South African Medical Research Council, Durban, Kwa-Zulu Natal, South Africa.
T ExnerDepartment of Psychiatry, Columbia University, New York, NY, USA.
L MillerICAP, Mailman School of Public Health, Columbia University, New York, NY, USA.ORCID https://orcid.org/0000-0001-6338-9349
C DolezalDepartment of Psychiatry, Columbia University, New York, NY, USA.
J Hanass-Hancock *Gender and Health Research Unit, South African Medical Research Council, Durban, Kwa-Zulu Natal, South Africa.ORCID https://orcid.org/0000-0003-3662-8548
S Hoffman *Department of Psychiatry, Columbia University, New York, NY, USA.ORCID https://orcid.org/0000-0002-1870-4853
South African Medical Research Council · ZANew York Psychoanalytic Society and Institute · USBrown University · USColumbia University · US

Funding

The Statistics, Data Science, and Data Management (SDM) CoreP30MH043520 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI Claude Ann Mellins · 2003 to 2026
$48.2M
Global HIV Implementation Science Research Training Grant RenewalT32AI114398 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Yael R Hirsch-Moverman · 2014 to 2026
$4.1M
Developing a Gender-Enhanced PrEP Information-Motivation Workshop for Young South African WomenR34MH115781 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI HANASS-HANCOCK, JILL, HOFFMAN, SUSIE · 2018 to 2020
$641k
GENERAL ETHNIC IDENTITY DEVELOPMENT AND AFRICAN AMERICANF31MH011578 · NIMH · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI CHAVOUS, TABBYE M · 1997 to 1997
–
NIAID NIH HHS T32 AI114398NIMH NIH HHS F31 MH011578NIMH NIH HHS P30 MH043520NIMH NIH HHS R34MH11578NIMH NIH HHS R34 MH115781
6 · The paper itself

Abstract

Daily oral pre-exposure prophylaxis (PrEP) offers effective HIV prevention. In South Africa, PrEP is publicly available, but use among young women remains low. We explored young women's perceptions of PrEP to inform a gender-focused intervention to promote PrEP uptake. Six focus group discussions and eight in-depth interviews exploring perceptions of PrEP were conducted with forty-six women not using PrEP, ages 18-25, from central Durban. Data were thematically analyzed using a team-based consensus approach. The study was conducted among likely PrEP users: women were highly-educated, with 84.8% enrolled in post-secondary education. Qualitative data revealed intersecting social stigmas related to HIV and women's sexuality. Women feared that daily PrEP pills would be confused with anti-retroviral treatment, creating vulnerability to misplaced HIV stigma. Women also anticipated that taking PrEP could expose them to assumptions of promiscuity from the community. To address these anticipated community-level reactions, women suggested community-facing interventions to reduce the burden on young women considering PrEP. Concerns around PrEP use in this group of urban, educated women reflects layered stigmas that may inhibit future PrEP use. Stigma-reducing strategies, such as media campaigns and educational interventions directed at communities who could benefit from PrEP, should re-frame PrEP as an empowering and responsible choice for young women.

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisAdolescentAdultFemaleHumansSexualitySocial StigmaSouth AfricaYoung AdultAnti-HIV AgentsHIV stigmaPrEPSexualitySouth AfricaYoung women

Identifiers

PMID35218452
PMCPMC9378426
OpenAlexW4214616335

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.